Table 2.
Absolute eGFR and CIMT values during follow-up.
| Variables | Follow-Up 1 | ||||
|---|---|---|---|---|---|
| Baseline | 1-Year | 2-Year | 3-Year | 4-Year | |
| Stage 2 | |||||
| eGFR (mL/min/1.73 m2) | 73.78 ± 7.12 | 75.27 ± 7.23 | 76.49 ± 7.43 | 77.02 ± 8.05 | 76.28 ± 5.07 |
| CIMT (mm) | 0.74 ± 0.03 | 0.74 ± 0.03 | 0.75 ± 0.04 | 0.75 ± 0.04 | 0.76 ± 0.03 |
| Stage 4 | |||||
| eGFR (mL/min/1.73 m2) | 26.68 ± 2.95 | 25.10 ± 3.20 | 23.84 ±3.33 | 22.57 ± 2.29 | 21.23 ± 1.06 |
| CIMT (mm) | 1.13 ± 0.25 | 1.16 ± 0.25 | 1.20 ± 0.24 | 1.22 ± 0.21 | 1.25 ± 0.14 |
1 Data are derived from descriptive statistics. Data are expressed as mean ± standard deviation. Legend: CIMT—carotid intima-media thickness; eGFR—estimated glomerular filtration rate.